Skip to content

Clinical trials

Diabetic Neuropathies trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Country / region: Brazil Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20081
20101
20121
20161
20182
20192
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo General Hospital4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Brainfarma Industria Química e Farmacêutica S/A1
Carlos E Salas1
Eli Lilly and Company1
Hospital Ambroise Paré Paris1
Instituto de Cardiologia do Rio Grande do Sul1
Irmandade da Santa Casa de Misericordia de Sao Paulo1
Rinaldo Roberto de Jesus Guirro1
Roberto Léo da Silva1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies15
Diabetic Foot5
Diabetes Mellitus3
Neuralgia3
Diabetes Mellitus, Type 22
Neuralgia, Postherpetic2
Peripheral Nervous System Diseases2
Diabetes Mellitus, Type 11
Diabetic Cardiomyopathies1
Foot Ulcer1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.